With the right structure, Americans will roll up their sleeves, do the science, and trust the result,” Manoush Zomorodi ...
Relatively speaking, the least controversial application of human embryo genome editing is to use it to try to prevent ...
Exclusive: STAT has learned that Eli Lilly and the FDA allowed a 79-year-old to gain extraordinary access to an experimental ...
EchoNext, a new AI tool cleared by the FDA, will let doctors use an EKG to easily screen patients for structural heart ...
Eli Lilly and the FDA have allowed one person to receive the pharma company’s highly promising obesity candidate through the ...
The federal government can't block benefits from the nation's largest food aid program from being used to buy candy, soda, ...
Digital health startup Cadence has raised $100 million at a $1.23 billion valuation to expand its chronic disease management ...
A new gene-editing startup negotiated contracts with a Chinese company, raised $230 million in funding, and executed a ...
An abandoned heart-failure trial offers a rare window into devices that the FDA deems "breakthrough" but never reach patients.
Back in 2020, STAT named promising young researcher Pierre Elias to our annual list of Wunderkinds. Today, I published a ...
Sanofi said that Paulo Fontoura, the chief medical officer at Xaira, would be taking over as its head of R&D, as the company ...
WASHINGTON — The Justice Department on Tuesday announced criminal charges against 455 people as part of a two-week health care fraud crackdown that officials say involved more than $6.5 billion in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results